Eli Lilly

The Future of Sanofi's Insulin Empire
Motley Fool
Fri, 07/19/13 - 10:17 am
Sanofi
insulin
Eli Lilly
Novo Nordisk
diabetes
U300
Lantus
LixiLan
Eli Lilly to freeze employee base pay ahead of generic onslaught
Yahoo/Reuters
Wed, 07/17/13 - 10:52 pm
Eli Lilly
generics
Lilly Goes All In On Solanezumab
Seeking Alpha
Sat, 07/13/13 - 12:07 pm
Eli Lilly
solanezumab
Alzheimer's disease
Eli Lilly's Management Hosts Update on Solanezumab Call (Transcript)
Yahoo/Seeking Alpha
Sat, 07/13/13 - 12:07 pm
Eli Lilly
solanezumab
Alzheimer's disease
Lilly Aims Alzheimer’s Treatment at Early Stage Patients
Bloomberg
Fri, 07/12/13 - 10:10 am
Eli Lilly
Alzheimer's disease
solanezumab
CMS Denies Amyvid Coverage: A Bigger Message To Biopharma
Elsevier Business Intelligence
Fri, 07/12/13 - 08:47 am
Eli Lilly
CMS
Amyvid
Alzheimer's disease
Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
Seeking Alpha
Wed, 07/10/13 - 10:25 am
Merck
diabetes
Novo Nordisk
Eli Lilly
Novartis
Januvia
Medicare officials say more studies needed before plan covers Eli Lilly's Alzheimer's agent
Yahoo/AP
Mon, 07/8/13 - 12:25 pm
Medicare
Eli Lilly
Alzheimer's disease
Amyvid
Lilly CEO returns after May aorta surgery
Yahoo/AP
Mon, 07/8/13 - 09:44 am
John Lechleiter
Pharma CEOs
Eli Lilly
Eli Lilly and Company and Boehringer Ingelheim announce regulatory submission for new insulin glargine biosimilar product
Yahoo
Mon, 07/8/13 - 09:43 am
diabetes
Eli Lilly
Boehringer Ingelheim
Europe
LY2963016
long-acting insulin
biosimilars
Medicare Limits Coverage of Lilly’s Drug for Brain Scans
Bloomberg
Wed, 07/3/13 - 10:06 pm
Medicare
Eli Lilly
Alzheimer's disease
Merck: Implications Of Capital Allocation
Seeking Alpha
Wed, 07/3/13 - 11:07 am
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Merck
capital allocation
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Eli Lilly
diabetes
dulaglutide
JNJ
Merck
Novo Nordisk
Bristol-Myers Squibb
3 Sources Of Revenue For Incyte
Seeking Alpha
Thu, 06/27/13 - 12:51 am
Incyte
Gilead
Eli Lilly
Novartis
Sanofi
6 Reasons Why Loss of Viagra Patent Will Not Harm Pfizer
Motley Fool
Tue, 06/25/13 - 11:29 am
Viagra
Pfizer
patents
Eli Lilly
GSK
erectile dysfunction
Eli Lilly Wins U.K. Patent Suit on J&J Alzheimer’s Research
Bloomberg
Tue, 06/25/13 - 11:25 am
Eli Lilly
UK
patents
JNJ
Alzheimer's disease
Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
Yahoo/PR NewsWire
Sun, 06/23/13 - 11:19 am
LY2605541
Eli Lilly
insulin
type 1 diabetes
diabetes
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Pipeline Vs. Expiring Patents: Eli Lilly's Future
Seeking Alpha
Thu, 06/20/13 - 11:00 am
Eli Lilly
patents
empagliflozin
dulaglutide
ixekizumab
ramucirumab

Pages